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ABSTRACT
Matrix-based tablets using different concentrations of grewia gum, and the model drug ibuprofen, were
prepared using a wet granulation technique. Similar formulations were also prepared using HPMC, guar gum
or ethyl cellulose as the polymer matrix. In addition to tablet properties, swelling and erosion of tablets and
kinetics of drug release were also investigated. In vitro drug release studies, in phosphate buffer (pH 7.2) using
USP type II apparatus, revealed that grewia gum at concentrations of 16%, 32% and 48% can sustain the
release of ibuprofen tablets for up to 24 hours. Release profiles were similar to those tablets containing ethyl
cellulose as the matrix former. Swelling and erosion of grewia gum matrices occurred simultaneously, and
ibuprofen release was by anomalous diffusion in accordance with the Korsmeyer-Peppas model. There was
evidence suggesting synergism between grewia gum and guar gum in sustaining the release of ibuprofen from
tablets when used in the ratio 2:1. Grewia gum may therefore prove a useful excipient, when used on its own,
or in combination with other polymers, to modify drug release. 
KEY WORDS: Ibuprofen, swelling, erosion, drug release, release profile, controlled delivery
INTRODUCTION
The aim of controlled delivery of drugs is to
deliver the active ingredient at a controlled rate
over the desired period of time. The primary
objectives are, therefore, to ensure safety and to
improve efficacy of drugs, as well as to improve
patient compliance. A number of approaches
have been used to obtain controlled drug
release, but hydrophilic matrices are recognized
as the simplest and are the most widely used.
Drug release from hydrophilic matrix tablets
initially results from swelling upon ingestion
which causes a gel layer to form on the tablet
surface. This gel layer retards further ingress of
fluid and subsequent drug release. Sujjaareevath
et al., (1) have shown that in the case of
hydrophilic matrices, swelling and erosion of
the polymer occurs simultaneously, and both of
them contribute to the overall drug release rate.
It is well documented that drug release from
hydrophilic matrices show a typical time-
dependent profile (i.e. decreased drug release
with time because of increased diffusional path
length) (2, 3). Many controlled-release products
(including hydrophyllic and hydrophobic
matrices) are designed on the principle of
embedding the drug in a porous matrix. Liquid
penetrates the matrix and dissolves the drug,
which then diffuses into the exterior liquid (4).
The hydrophilic matrices form a gel through
which the drug must diffuse, while
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hydrophobic matrices like ethyl cellulose, show
little or no swelling. The release of drug from
the matrices is controlled by a network of
tortuous capillaries or channels which develop
as the drug is dissolved and released.
Polysaccharide gums are often used for oral
controlled delivery of medicines. Their ability to
hydrate and swell in aqueous media renders
them a viable platform as hydrophilic matrices
for time-dependent release of soluble or
insoluble drugs. Hydrophilic matrices from
natural polysaccharide gums such as xanthan
gum (5-8), guar gum (9-11) and karaya gum (12)
have been shown to provide varying degrees of
control over the release of medicines. These
natural hydrophilic colloids are widely used in
pharmaceutical dosage forms because of their
biocompatibility, low cost and relatively
abundant availability (13).
Grewia polysaccharide gum is obtained by
extraction from the inner stem bark of the plant
Grewia mollis (Fam. Tiliaceae). The plant grows
abundantly, wild or cultivated, in the middle
belt region of Nigeria and forms part of the
delicacies of the inhabitants of the region (14).
Aqueous dispersions of the pulverised inner
stem bark of grewia gum hydrates and swell to
form a highly viscous dispersion. This property
of the plant has kindled a lot of interest into the
potential application of the gum as a matrix for
oral controlled delivery of medicines. The gum
has been isolated and some physicochemical
(15-17), binding (18), rheological (19) and
mechanical properties of aqueous based grewia
gum films (20, 21) have been evaluated.
In this study matrix tablets of ibuprofen were
formulated by wet granulation using 16%, 32%
or 48% w/w of grewia gum. The tablet
properties and drug release from the tablets
were compared with corresponding tablets
made with hydrophilic matrix formers HPMC
or guar gum (reference polymers). The grewia
matrix tablets were also compared with similar
formulations using the more hydrophobic ethyl
cellulose. To evaluate synergism between grewia
gum and the reference polymers, binary
composite matrices of grewia gum and the
reference polymers were also prepared and
studied at total polymer concentration of 16%
w/w and polymer ratios of 1:1 (8% grewia gum
+ 8% reference polymer), 1:2 (5.33% grewia
gum + 10.67% reference polymer) and 2:1
(10.67% grewia gum + 5.33%w reference
polymer).
MATERIALS AND METHODS
Materials
Ibuprofen BP was donated by GSK Consumer
Health. Ethyl cellulose (Ethocel® - standard
100FP Premium, solution viscosity - 90-110 cP,
Molecular weight 880,000) was a gift from
Colorcon, UK.  HPMC (Metolose® - 90SH-
100SR, viscosity 100 mPa.s, substitution type-
2208, Molecular weight 230,000) was a gift
from R.W. Unwin, UK and colloidal silicon
dioxide (Aerosil 200®) was a gift from Evonik,
UK. Lactose monohydrate USP (Pharmatose®,
grade DCL14) was a gift from DMV-
International, UK. Guar gum (Molecular weight
250,000), and magnesium stearate (grade
Puriss.) were purchased from Sigma, UK.
Grewia gum (Pullulan equivalent average
molecular weight- 5925 KDa) was extracted in
our laboratory as detailed previously (17). 
Extraction of grewia gum
Grewia polysaccharide gum was extracted as
detailed previously (17). Briefly, the dried and
pulverized inner stem bark of the plant was
dispersed in 0.1% w/v sodium metabisulphite
and hydrated for 48 hours.  It was then passed
through a muslin bag. The filtrate was treated
with 0.1N NaOH and centrifuged (Miww
centrifuge, UK) at 3,000 rpm for 10 minutes. 
The supernatant was then treated with acidified
ethanol containing 0.1N HCl and centrifuged
again as described previously.  Absolute ethanol
was used to precipitate the supernatant and the
resultant precipitate repeatedly washed with
absolute ethanol until clear absolute ethanol
was recovered. The precipitate was wet-milled
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using a BL440 blender (Kenwood, UK) and
then passed through a muslin bag to remove
excess ethanol before air-drying the product.
The air-dried product was dry-milled before
further drying at 50oC in a size 2 fan-assisted
drying oven (Gallenkamp, UK) for 48 hours.
Preparation and analysis of tablets
Single polymer matrix granules of polymer,
lactose and ibuprofen were prepared using wet
granulation. All powders were passed through a
250 µm sieve before wet granulation. Briefly,
appropriate amount of polymer to provide
16%, 32% or 48% (w/w of ibuprofen) were
mixed with lactose monohydrate USP and
ibuprofen (Table 1) and the powder mass was
wetted with just enough distilled water to give a
damp and coherent, but loose, powder mass.
Mixing was carried out using a KMC560 mixer
(Kenwood, UK) at speed setting 3 rev/min.
Granulations using ethyl cellulose, HPMC or
guar gum were also prepared for comparison.
The moist mass was passed through a 710 µm
sieve to form granules which were dried at 50oC
overnight in an oven (Gallenkamp, UK).
Thereupon, particle-size analysis of the dried
granules was determined as outlined in next
section. Granule sizes of <250 µm were
discarded. The granule sizes between 355-
710 µm were then blended with magnesium
stearate and colloidal silicon dioxide, before
comp-ression on a single station press,
Minipress MII (RIVA, Germany) operated at a
speed of 50 tablets per min. 
Flat-faced tablets of 832 mg weight, 13 mm
diameter and hardness of 70.3 ± 8.9 N were
made. The compressed tablets were stored in
air-tight containers prior to evaluation of tablet
properties.
Table 1 Per tablet formula for Monolithic matrix tablets
of ibuprofen
Ingredients I II III
Ibuprofen (mg) 500 500 500
Polymer (mg) 80 160 240
Lactose monohydrate (mg) 220 140 60
Magnesium stearate (mg) 8 8 8
Colloidal silicon dioxide (mg) 24 24 24
Similarly, binary composite matrix tablets of
ibuprofen containing 16% w/w total polymer
concentration of grewia gum and guar, grewia
gum and ethyl cellulose or grewia gum and
HPMC in the ratio 1:1, 1:2 or 2:1 were made by
wet granulation. The amounts of ibuprofen,
lactose and polymers, as shown in Table 2, were
mixed and moistened with distilled water, and
the granules were prepared by wet granulation
as outlined above.
Characterization of granules
Moisture content of the granules was determined
using a Sartorius moisture balance (Sartorius,
Germany).   Angle  of  repose   was   determined
Table 2 Per tablet formula for binary composite matrix tablets of ibuprofen
I II III IV V VI VII VIII IX
Ibuprofen (mg) 500 500 500 500 500 500 500 500 500
Grewia (mg) 40 40 40 26.7 26.7 26.7 53.3 53.3 53.3
Ethyl cellulose (mg) 40 - - 53.3 - - 26.7 - -
HPMC (mg) - 40 - - 53.3 - - 26.7 -
Guar (mg) - - 40 - - 53.3 - - 26.7
Lactose (mg) 220 220 220 220 220 220 220 220 220
Colloidal silicon dioxide
(mg) 24 24 24 24 24 24 24 24 24
Magnesium stearate (mg) 8 8 8 8 8 8 8 8 8
This Journal is © IPEC-Americas Inc J. Excipients and Food Chem. 2 (1) 2011 -  5 
Original Paper
by weighing accurately the granules into a
funnel. The height of the funnel was adjusted
so that it just touched the apex of the heap of
granules. The granules were allowed to flow
through the funnel freely onto a flat surface.
The diameter of the powder cone was
measured and angle of repose was calculated
using the following equation:
Tan θ = h/r Eq. 1
Where, h and r are the height and radius of the
powder cone.
Bulk and tapped density were determined using
a USP tap density tester (Sotax TD2,
Switzerland). The compressibility index of the
granules was determined according to Carr’s
compressibility index percentage.
Granule size analysis was carried out by
accurately weighing and transferring 30 g of
granules into the arrangement of sieve sizes
710, 500, 355 and 250 µm respectively. The
sieves were arranged such that the largest size
(710 µm) is on top and the smallest (250 µm)
sitting on top of the collector. The sieve
analyzer (Fritsch Analysette 3 SPARTAN,
Germany) was set to 12 minutes with amplitude
of 1.0 mm. At the end of the run time the
granules on top of each sieve was collected and
weighed. Granules <250 µm were discarded.
Characterization of tablets
Crushing strength, friability, uniformity of
weight and content of the tablets were
evaluated. Tablet crushing strength was tested
with a model 6D tablet tester (Schleuniger
Pharmatron, Manchester, NH). Friability was
tested using friability testing apparatus (Roche
type). The uniformity of weight test (20 tablets)
was carried out on an analytical balance.
Uniformity of content test (10 tablets) was
carried out on all batches of matrix tablets in
phosphate buffer (pH 7.2) and UV absorbance
read at 265 nm on a Mattson Galaxy 3020 UV
spectrophotometer (Unicam, UK). The
calibration curve gave a regression coefficient
of 0.9984 and the standard error of the slope
was 0.0198.
In vitro drug release studies
The release of drug from the matrix tablets of
ibuprofen was studied in 900 ml of 0.1M
phosphate buffer (pH 7.2) using USP II (paddle
method) at 100 rpm and 37 ± 1°C equipped
with a 40 mesh sinker (DT 600, Erweka,
Germany). A 4 ml sample was taken  at time
intervals of 15 minutes, 30 minutes and
thereafter every 1 hour for 12 hours for both
single polymer and binary systems. Further
samples from the single polymer systems were
taken after 24, 25 and 26 hours. The samples
were filtered through syringe filters (pore size =
0.45 µm) before assaying for drug content using
the UV-spectrophotometer at 265 nm. After
each sample was removed, it was replaced with
an equal volume (4 ml) of fresh buffer solution
at the same temperature. All experiments were
run in triplicate.
Water uptake and erosion studies
Water uptake and erosion studies were also
carried out using the DT 600 dissolution
apparatus. The matrix tablets, in a sinker, were
placed in 900 ml of phosphate buffer (pH 7.2)
equilibrated at 37 ± 1°C and the paddle was
rotated at 100 rpm. The tablets were allowed to
hydrate, swell and erode for a range of
durations. Two tablets were used per time
point. At predetermined intervals (0, 30
minutes, 1, 2, 4 or 8 hours), the tablets were
removed from the dissolution vessel and lightly
patted with tissue paper to remove excess
water. The wet weight of the tablets was
determined and they were then dried at 50°C
until a constant weight was obtained. This
remaining dry weight was recorded. Water
uptake and erosion were determined
gravimetrically according to the following
equations:
Eq. 2Water uptake wet weight  remaining  dry weight
remaining  dry  weight
x 100(%)   
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Eq. 3
Kinetic analysis of dissolution data
The mechanism of drug release from the tablet
matrices was studied by fitting the release data
into the zero-order, first-order and Higuchi
kinetic equations (22):
Zero order: Qt = Q0 + K0t Eq. 4
First order: lnQt = lnQ0 + K1t Eq. 5
Higuchi: Qt = KHt½ Eq. 6
These models fail to explain drug release
mechanism due to swelling (upon hydration)
along with gradual erosion of the matrix.
Therefore, the dissolution data was also fitted
to the well-known exponential equation
(Korsmeyer equation), which is often used to
describe drug release behaviour from polymeric
systems (23):
Log (Mt/Mf) = Log k + n Log t Eq. 7
Where, Mt is the amount of drug release at time
t,  Mf is the amount of drug release after infinite
time, k is a release rate constant incorporating
structural and geometric characteristics of the
tablet, and n is the diffusion exponent indicative
of the mechanism of drug release.
To determine the release exponent, the log
value of percentage drug dissolved was plotted
against log time for each batch according to the
equation. A value of n = 0.45 indicates Fickian
(case I) release; 0.45< n <0.89 indicates non-
Fickian (anomalous) release; and >0.89
indicates super case II type of release. Case II
generally refers to the erosion of the polymeric
chain, and anomalous transport (non-Fickian)
refers to a combination of both diffusion and
erosion controlled drug release (24).
The similarity factor f2 as proposed by Moore
and Flanner (33) was used to compare
dissolution between the test polymer and the
reference polymers.
Eq. 8
Where, n = number of observations made, 
Rt = average percentage drug dissolved from
reference formulation at time t and Tt =
average percentage drug dissolved from test
formulation at time t.
Statistical Analysis
The data were analysed using one-way ANOVA
(Instat software, GraphPad, San Diego, CA). 
RESULTS AND DISCUSSION
Granule properties
The granules of single polymer matrix tablets
and binary composite matrix tablets were
prepared according to the formulae in Tables 1
and 2 respectively. Angle of repose was
between 27° and 33° for all the batches of
granules indicating ‘good’ to ‘passable’ flow
behaviour while the values for Carr’s
compressibility indicate poor flow (25, 26).
Consequently, the flow of all batches of
granules was improved by the use of colloidal
silicon dioxide.
The particle size and size analysis of single
polymer and binary composite granules are
presented in Figures 1a and 1b respectively.
The particle-size distribution of the granules
show that single polymer granules of grewia
(16%, 32%), guar (16%, 32%, 48%), and
HPMC (48%) predominantly consist of smaller 
particle sizes (fines) of <250µm. Inter-
particulate attraction tends to be higher in fine
particles and are therefore more cohesive and
less free flowing. Granules made of binary
composites all predominantly consisted of
particles of <250 µm, except granules
consisting of grewia/ethyl cellulose (1:2 and
1:1). To improve flow, granules <250 µm were
discarded.
Erosion 
original weight  remaining dry weight
original  weight
x 100(%)       


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Tablet properties
All formulations passed the uniformity of
weight test with no single tablet deviating from
the mean (n = 20) weight by >5%. There was a
high degree of chipping of guar gum in both
singular and binary composite matrices
accounting for high friability values with the
exception of grewia/guar (2:1) matrices.
Capping was seen in grewia/ethyl cellulose (1:1)
matrices. Drug content was between 94.0%-
96.5% for all the formulations. All other
formulations demonstrated satisfactory tablet
properties including friability (<1.0 %) and a
crushing strength of 70.3 ± 8.9 N and 72.8 ±
10.1 N for the single polymer matrices and
binary composite matrices respectively.
In vitro release of ibuprofen from tablets 
Effect of polymer type and concentration on drug
release from single polymer matrices
Drug release profiles for ibuprofen from single
polymer matrix tablets containing 16 %, 32 %
or 48 %w/w of grewia, guar, HPMC or ethyl
cellulose are shown in Figures 2 a-c. 
Figure 1 (a)  Particle-size distribution of granules for
monolithic tablets of ibuprofen (n=3, mean±s.d.)
Figure 1 (b) Particle-size distribution of granules for
binary composite matrices of ibuprofen (n=3, mean ±
s.d.)
Figure 2 (b) Release profiles of ibuprofen from the
matrices containing 32% w/w of grewia, guar, HPMC, or
ethyl cellulose in phosphate buffer solution at 37± 1oC
(n=3, mean ± s.d.)
Figure 2 (c) Release profiles of ibuprofen from the
matrices containing 48% w/w of grewia, guar, HPMC, or
ethyl cellulose in phosphate buffer solution at 37± 1oC
(n=3, ± s.d.)
Figure 2 (a) Release profiles of ibuprofen from the
matrices containing 16% w/w of grewia, guar, HPMC or
ethyl cellulose in phosphate buffer solution at 37± 1oC
(n=3, mean ± s.d.)
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There was no initial burst release from the
grewia, HPMC and ethyl cellulose matrices
(defined as more than 30% drug release in the
first hour indicating the likelihood of dose
dumping (27)). However, differences between
these polymers in the initial release could be
seen. Figure 2a shows that more than 48% of
drug was released within the first hour for
matrix tablets prepared using 16% w/w guar
gum. At 32% and 48% w/w (Figures 2 b and
c), tablets prepared using guar gum also
resulted in a burst effect which can be
attributed to surface erosion or initial
disaggregation of the matrix tablet prior to gel
layer formation around the tablet core (28).
This is also confirmed by the water uptake and
erosion with time profiles for these polymer
matrices (shown in Figures 3a and 3b
respectively). The absence of burst effect with
ethyl cellulose matrices is attributable to the
hydrophobic nature of ethyl cellulose which
causes reduction in the penetration of the
solvent molecules into the matrix (27).
The difference in the mechanism of drug
release between hydrophilic and hydrophobic
matrices is attributable to the observed
differences in drug release profiles of the
polymer matrices. The hydrophobic ethyl
cellulose matrices do not swell or form gels.
The water repellent nature of polymer reduces
water ingress into the polymer matrix and  drug
release from the matrices is primarily controlled
by network of tortuous capillaries or channels
which develop as the drug is dissolved and
released (27). Consequently, ethyl cellulose
matrices were more effective than the
hydrophilic matrices of grewia gum, guar gum
and HPMC in delaying the release of drug. The
hydrophilic matrices swell and form a gel across
which the drug must diffuse. The ability to
delay release is controlled by the lengths of the
diffusion path across the matrix core at any
given time. The ability of grewia gum to delay
the release of the drug was second only to ethyl
cellulose. Although grewia gum is hydrophilic
in nature it is only slightly soluble in water (17)
compared to guar gum which is soluble in
water. This low solubility of grewia gum implies
that drug release from the matrix core of grewia
matrices may occur in a similar manner as ethyl
cellulose matrices, the rate and extent of
diffusion across the matrix being reduced by
the insoluble matrix core.
Table 3 shows the time for 50% drug released
50(t ) from  the single polymer matrices. The
results show very rapid release of ibuprofen
from guar gum matrices closely followed by
HPMC matrices. At 16%, 32% and 48% w/w
polymer concentration, there was no significant
50difference (P>0.05)  in  the t   between  grewia
polysaccharide gum  and  ethyl   cellulose,  both
matrices providing a more sustained release of
ibuprofen than HPMC (P<0.001) at 48%  w/w 
50Table 3 Time for 50% ibuprofen release (t ) and
Figure. 3  (a) Water uptake with time of single polymer
matrices (48%), (n=2). 
Figure 3 (b) erosion with time of single polymer
matrices (48%), (n=2).
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% ibuprofen release from single polymer  matrices after
24 hours in phosphate buffer (pH 7.2), (n=3, mean ±
s.d.)
50Formulation t  (min) % release (24h)
Grewia 16% 440.0  ±  21.2 86.6  ±  2.5
Grewia 32% 574.6  ±  22.1 80.6  ±  0.8
Grewia 48% 806.6  ±  90.1 71.1  ±  1.1
Guar 16% 13.3  ±  2.9 94.7  ±  1.0
Guar 32% 130.0  ±  17.3 91.3  ±  3.2
Guar 48% 220.0  ±  34.6 85.5  ±  4.2
HPMC 16% 213.3  ±  15.3 94.0  ±  1.8
HPMC 32% 320.0  ±  138.6 89.4  ±  3.9
HPMC 48% 496.7  ±  28.9 68.3  ±  2.0
Ethyl cellulose 16% 413.3  ±  30.6 84.2  ±  1.0
Ethyl cellulose 32% 520.0  ±  26.5 75.6  ±  8.3
Ethyl cellulose 48% 920.0  ±  346.3 59.8  ±  7.0
polymer concentration or guar gum at all
polymer concentrations (P<0.001). The results
also show that the ability to delay the release of
ibuprofen from the polymeric matrix tablets
increases with an increase in the concentration
of the polymer from 16% to 48% w/w. 
Drug release from binary matrices
Release profiles for ibuprofen from polymer
binary composites are presented in Figures 4 a-
c. There was no burst effect with any batches
of matrix tablets containing grewia and HPMC
or ethyl cellulose (1:1, 1:2 and 2:1) and this is
probably due to the low surface erosion of
grewia gum. However, at a 1: 2 ratio of grewia
to guar gums, this low surface erosion was
offset by the high surface erosion of guar with
>48 % drug release in the first 15 minutes
(Figure 4a). 
The delay in release of ibuprofen was highest
for composite matrix tablets of grewia/guar
(2:1), closely followed by grewia/HPMC (2:1)
(Table 4).
There is a significant improvement in the ability
of grewia gum or guar gum  (2:1)  to  delay  the
50Table 4 Time for 50% ibuprofen release (t ) and %
ibuprofen release from binary matrices after 12 hours in
phosphate buffer (pH 7.2), (n=3, mean ± s.d.)
Form ulation t50 (m in) % release (12 h)
Grewia/Guar (1:2) 13.3±1.5 97.3±2.8
Grewia/Guar (1:1) 306.0±15.1 74.3±0.8
Grewia/Guar (2:1) 557.7±18.0 60.6±1.8
Grewia/HPMC (1:2) 185.7±23.1 88.5±0.9
Grewia/HPMC (1:1) 235.3±35.6 80.6±5.1
Grewia/HPMC (2:1) 405.0±8.7 68.6±1.4
Grewia/Ethyl cellulose (1:2) 273.3±25.2 82.5±3.3
Grewia/Ethyl cellulose (1:1) 206.7±35.1 98.0±2.7
Grewia/Ethyl cellulose (2:1) 316.0±14.2 79.6±1.7
Figure 4 Release profiles of ibuprofen from the
composite matrices containing 16% w/w of grewia and
guar, HPMC, or ethyl cellulose in the ratio (a) 12, (b)
11 and (c). 21, in phosphate buffer solution at 37± 1 Co
(n=3, mean ± s.d.)
This Journal is © IPEC-Americas Inc J. Excipients and Food Chem. 2 (1) 2011 -  10 
Original Paper
release of ibuprofen when used as composite
matrices, rather than as a single polymer matrix.
50 The t of either grewia or guar gum single
polymer matrices (16% w/w total polymer
concentration) were 440.0 ± 21.2 and 13.3 ± 2.9
minutes respectively, but when combined in the
ratio 2:1 (10.67% grewia gum + 5.33% guar
50 gum), the t was extended to 557.7 ± 18.0
minutes. This represents a significant impro-
vement (P<0.001) in the ability of the binary
composite to delay ibuprofen release. The
increase in the ability of the matrices to delay
release of drug may be attributed to the higher
proportion of grewia gum in the grewia/guar
(2:1) binary composite matrices. The synergy
between grewia and guar gum may be
attributed to interaction between the two gums.
The binary composite of grewia and HPMC
(2:1) does not present a significant impro-
vement in sustained release of ibuprofen when
compared to grewia 16% single polymer
matrices (P>0.05). This was however significant
when compared with guar 16% single polymer
matrix tablets (P<0.001). All other binary
composites of the polymer matrix tablets of
50 ibuprofen gave t values which were less than
the corresponding single polymer (16%) matrix
tablets.
The results also show that increasing the
concentration of grewia gum in the binary
composite formulations enhances the ability of
the matrices to delay the release of the drug
(Figures 4 a-c). At all concentrations the ability
to delay release of drug from the binary
matrices was in the order: grewia/ethyl
cellulose > grewia/HPMC > grewia/guar.
Swelling and erosion
Both swelling and erosion occur simultaneously
in the tablet matrices but to varying extents
(Figures 4 a-b shows the results for 48% w/w
matrices as an example). Consequently a
constant release rate of drug can be expected
from the single polymer matrices (29) as the
increase in diffusion path length, which occurs
due to swelling, is compensated for by the
simultaneous erosion of the matrix (30). The
very low water uptake by ethyl cellulose
matrices may be attributed to the hydrophobic
nature of the ethyl cellulose matrices.
The water uptake and erosion plots selected for
binary composite matrices (1:2 and 2:1) are
shown in Figures 5a-d. The results show that
erosion and water uptake occur simultaneously
for all batches. The complete erosion of
grewia/guar (1:2) tablet matrices occurred
within 2 hours probably due to low mechanical
strength of the tablets resulting in the inability
of this polymer combination to sustain the
release of ibuprofen from the matrix tablets.
The predominant effect of grewia gum is
shown by the reduction in the erosion of
grewia/guar (2:1) matrices (Figure 5d) as
against grewia/guar (1:2) matrices (Figure 5b).
This result supports the dissolution results and
show that grewia gum reduces the rate and
extent of erosion of guar gum matrices with a
consequent enhancement of the ability of
binary matrices (grewia/guar (2:1)) to delay the
release of drug from the matrices. 
Release mechanism and kinetics
The kinetic data for all the single polymer
matrices and binary composite matrices are
shown in Table 5. Drug release data from
grewia single polymer matrices (16%, 32% and
48% w/w) all showed highest correlation with
the Korsmeyer-Peppas kinetic models. The
16% w/w grewia single polymer matrix tablets
show linearity with Higuchi and Korsmeyer-
Peppas kinetic models (P>0.05). In addition,
grewia 48% w/w single polymer matrix tablets
show good correlation with Korsmeyer-Peppas
kinetic model. The value of n for all the grewia
single polymer matrices ranged between 0.7 to
0.8 and since there is no significant difference
(P>0.05) between the correlation coefficient of
the zero order kinetics and Korsmeyer-Peppas
model, it can be concluded that drug release
was by anomalous transport and always
approximately zero order for a significant part
of the total release time (31). The release
exponent for all HPMC matrix  tablets indicate
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Table 5 The release kinetics of single polymer matrix tablets of ibuprofen (n=3, mean ± s.d.)
Formulation Diffusion exponent
(n)
Korsmeyer-
Peppas (r )2
Zero order (r ) First-order(r ) Higuchi (r ) Similarity2 2 2
2factor (f )
Grewia 16% 0.8  ±  0.08 0.99  ±  0.00 0.98  ±  0.00 0.782  ±  0.03 0.98  ±  0.01 -
Grewia 32% 0.7  ±  0.04 0.95  ±  0.02 0.99  ±  0.01 0.886  ±  0.05 0.94  ±  0.01 -
Grewia 48% 0.7  ±  0.03 0.99  ±  0.00 0.99  ±  0.00 0.85  ±  0.01 0.97  ±  0.00 -
Guar 16% N/A N/A 0.68  ±  0.03 0.64  ±  0.04 0.84  ±  0.02 16.2  ±  0.4
Guar 32% 0.2  ±  0.04 0.96  ±  0.02 0.93  ±  0.05 0.87  ±  0.08 0.98  ±  0.02 26.1  ±  0.6
Guar 48% 0.3  ±  0.07 0.97  ±  0.02 0.93  ±  0.02 0.82  ±  0.07 0.98  ±  0.01 25.9  ±  1.5
HPMC 16% 0.7  ±  0.06 0.99  ±  0.01 0.92  ±  0.01 0.76  ±  0.02 0.98  ±  0.00 32.8  ±  0.3
HPMC 32% 0.7  ±  0.04 0.98  ±  0.00 0.94  ±  0.02 0.77  ±  0.03 0.99  ±  0.00 34.2  ±  0.9
HPMC 48% 0.8  ±  0.03 0.99  ±  0.00 0.99  ±  0.00 0.82  ±  0.03 0.98  ±  0.00 42.9  ±  2.5
Ethyl cellulose 16% 0.6  ±  0.05 0.98  ±  0.01 0.99  ±  0.01 0.85  ±  0.02 0.99  ±  0.01 70.4  ±  4.1
Ethyl cellulose 32% 0.6  ±  0.03 0.98  ±  0.00 0.99  ±  0.00 0.88  ±  0.00 0.98  ±  0.00 61.9  ±  4.6
Ethyl cellulose 48% 0.6  ±  0.03 0.99  ±  0.00 0.98  ±  0.00 0.84  ±  0.00 0.99  ±  0.00 61.3  ±  5.9
Grewia/Guar (1:1) 0.5  ±  0.04 0.99  ±  0.00 0.95  ±  0.01 0.79  ±  0.02 0.99  ±  0.00 51.4  ±  2.3
Grewia/Guar (1:2) N/A N/A 0.69  ±  0.09 0.75  ±  0.04 0.78  ±  0.10 14.5  ±  1.9
Grewia/Guar (2:1) 0.5  ±  0.02 0.96  ±  0.01 0.99  ±  0.00 0.92  ±  0.01 0.98  ±  0.01 61.1  ±  2.1
Grewia/ HPMC (1:1) 0.6  ±  0.05 0.98  ±  0.01 0.92  ±  0.02 0.75  ±  0.04 0.98  ±  0.01 42.7  ±  6.0
Grewia/ HPMC (1:2) 0.5  ±  0.07 0.98  ±  0.01 0.92  ±  0.02 0.76  ±  0.05 0.99  ±  0.01 33.9  ±  1.1
Grewia/ HPMC (2:1) 0.5  ±  0.04 0.98  ±  0.02 0.98  ±  0.00 0.88  ±  0.02 0.99  ±  0.01 65.5  ±  1.7
Grewia/Ethyl cellulose (1:1) 0.7  ±  0.06 0.98  ±  0.00 0.94  ±  0.03 0.73  ±  0.06 0.99  ±  0.01 32.7  ±  4.2
Grewia/Ethyl cellulose (1:2) 0.7  ±  0.04 0.99  ±  0.01 0.95  ±  0.00 0.76  ±  0.04 0.99  ±  0.01 45.8  ±  4.1
Grewia/Ethyl cellulose (2:1) 0.7  ±  0.01 0.99  ±  0.00 0.97  ±  0.00 0.82  ±  0.002 0.99  ±  0.00
52.6  ±  1.9
that drug transport was by a non-Fickian
mechanism. There was correlation with more
than one release model. HPMC, like other
hydrophilic polymers, forms matrices in which
the overall release rates of drug  from  the  mat-
rices are controlled by swelling and erosion
which occur simultaneously (1, 32). Drug
release from ethyl cellulose single polymer
matrix tablets also showed linearity with more
than one kinetic model. The release exponent
Figure 5 (a) Water uptake with time and (b)  erosion with time of binary composite matrices (ratio 12), (c) water
uptake with time and (d) erosion with time of binary composite matrices (ratio 21), (n=2). 
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indicated that drug transport was by anomalous
or non-Fickian mechanisms.
Drug release from all the binary composite
matrices showed linearity with a number of
kinetic models (Table 5). The kinetic exponents
were all indicative of non-Fickian or anomalous
transport although the release exponent n could
not be calculated for the 16% w/w guar single
polymer matrices and grewia/guar (1:2) binary
matrices because there were insufficient data
points on the release profiles between 10% and
60% release to provide accurate values.
2The similarity factor f  (33) which was derived
from a pair-wise model independent procedure
was used to assess the similarity between the
dissolution profiles. The test profiles were
grewia 16%, 32% and 48% for the single
polymer matrices while grewia 16% was the test
2profile for the binary composite matrices. An f
of 100 suggests that the test and reference
profiles are identical. As the value decreases,
the dissimilarity between the release profiles
increases. 
Ethyl cellulose formulations were most similar
to the grewia-based formulations for drug
release (Table 5). The guar gum single polymer
matrices were the least similar formulations to
grewia single polymer matrices at all
concentrations. The hydrophilic matrices
control drug release by swelling and diffusion
across the gel layer. Ethyl cellulose has water
repelling properties and, unlike hydrophilic
polymers like HPMC, guar or grewia, its
hydrophobic nature repels water from
penetrating the tablet matrix and as a result
retards drug release from the tablet matrix (34).
The similarity between the dissolution profiles
of grewia matrices and ethyl cellulose matrices
may be attributable to the fact that grewia gum
only hydrates and swells in aqueous media but
dissolution of the gel does not occur owing to
low solubility of the gum in water (17).
The binary composite matrices with the highest
2f  were grewia/guar (2:1), grewia/HPMC (2:1)
and grewia/ethyl cellulose (2:1), indicating the
highest similarity to grewia alone (16% w/w).
At higher levels of grewia gum within the
matrix, its properties may be seen to dominate
and impact the drug release. 
CONCLUSION
The results from this study indicate that grewia
polysaccharide gum can provide sustained
release of ibuprofen from matrix tablets for up
to 24 hours. Physicochemical properties such as
high molecular weight, low solubility, high
viscosity and long swelling time (17) makes
grewia polysaccharide gum a suitable insoluble
polymer matrix for the release of active drugs.
The release profiles bear greatest similarity to
ethyl cellulose. The drug release was by
anomalous diffusion and approximates zero
order for the most part of the release. The
present study also indicates synergism between
grewia gum and guar gum (total polymer
concentration of 16% w/w) when combined in
matrix formulations of ibuprofen in the ratio of
2:1 (10.67% grewia gum +5.33% guar gum). Its
relative abundant availability and low cost
makes it an economically viable alternative
source of excipient for both the food and
pharmaceutical industry. When the sustained-
release of an API is indicated, grewia may
therefore not only have economical advantages
over HPMC and guar gum, but may also extend
the duration of release.
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